Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary Remove Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Paediatric investigation plans Remove Paediatric investigation plans filter Referrals Remove Referrals filter Summaries of opinion (4) Apply Summaries of opinion filter Withdrawn applications (9) Apply Withdrawn applications filter Orphan designations (70) Apply Orphan designations filter Direct healthcare professional communication (15) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (1) Apply Yes filter

Authorisation status

Authorised (192) Apply Authorised filter Refused (2) Apply Refused filter Withdrawn (35) Apply Withdrawn filter

ATC code

Species

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (7) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (53) Apply PM: decision on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (1) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter W: decision granting a waiver in all age groups for all conditions or indications (13) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (16) Apply Yes filter

Compliance procedure number

Referral name

Referral status

European Commission final decision (4) Apply European Commission final decision filter Procedure started (1) Apply Procedure started filter

Referral safety status

Yes (1) Apply Yes filter

Referral type

Article 20 procedures (4) Apply Article 20 procedures filter Article 31 referrals (1) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter PRAC-CHMP-EC (2) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (1) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (4) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (3) Apply Risk minimisation measures filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Accelerated assessment Remove Accelerated assessment filter Biosimilar Remove Biosimilar filter Conditional approval Remove Conditional approval filter Exceptional circumstances Remove Exceptional circumstances filter Additional monitoring (572) Apply Additional monitoring filter Generic (318) Apply Generic filter Orphan medicine (246) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

308 results

Remove all filtersRemove all filters

Categories Human Remove Human filter Veterinary Remove Veterinary filter

Medicine Referrals Remove Referrals filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Paediatric investigation plans Remove Paediatric investigation plans filter

Medicine type Accelerated assessment Remove Accelerated assessment filter Exceptional circumstances Remove Exceptional circumstances filter Biosimilar Remove Biosimilar filter Conditional approval Remove Conditional approval filter

Sort by

List item

Human medicine European public assessment report (EPAR): Hyrimoz (updated)

adalimumab, Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing; Uveitis; Hidradenitis Suppurativa; Colitis, Ulcerative; Arthritis, Juvenile Rheumatoid; Crohn Disease; Skin Diseases, Papulosquamous
Date of authorisation: 26/07/2018, , , Revision: 10, Authorised, Last updated: 22/02/2023
List item

Human medicine European public assessment report (EPAR): Lamzede (updated)

velmanase alfa, alpha-Mannosidosis
Date of authorisation: 23/03/2018, , , , Revision: 6, Authorised, Last updated: 22/02/2023
List item

Human medicine European public assessment report (EPAR): Natpar (updated)

parathyroid hormone, Hypoparathyroidism
Date of authorisation: 24/04/2017, , , , Revision: 14, Authorised, Last updated: 22/02/2023
List item

Human medicine European public assessment report (EPAR): Remsima (updated)

infliximab, Arthritis, Psoriatic; Spondylitis, Ankylosing; Colitis, Ulcerative; Psoriasis; Crohn Disease; Arthritis, Rheumatoid
Date of authorisation: 10/09/2013, , Revision: 32, Authorised, Last updated: 20/02/2023
List item

Human medicine European public assessment report (EPAR): Accofil

filgrastim, Neutropenia
Date of authorisation: 17/09/2014, , Revision: 13, Authorised, Last updated: 16/02/2023
List item

Human medicine European public assessment report (EPAR): Enhertu

trastuzumab deruxtecan, Breast Neoplasms
Date of authorisation: 18/01/2021, , , Revision: 10, Authorised, Last updated: 16/02/2023
List item

Human medicine European public assessment report (EPAR): Ondexxya

andexanet alfa, Drug-Related Side Effects and Adverse Reactions
Date of authorisation: 26/04/2019, , , Revision: 13, Authorised, Last updated: 15/02/2023
List item

Human medicine European public assessment report (EPAR): Strensiq

asfotase alfa, Hypophosphatasia
Date of authorisation: 28/08/2015, , , , Revision: 16, Authorised, Last updated: 15/02/2023
List item

Human medicine European public assessment report (EPAR): Hefiya

adalimumab, Spondylitis, Ankylosing; Hidradenitis Suppurativa; Psoriasis; Arthritis, Juvenile Rheumatoid; Uveitis
Date of authorisation: 26/07/2018, , , Revision: 11, Authorised, Last updated: 13/02/2023
List item

Human medicine European public assessment report (EPAR): Benepali

etanercept, Arthritis, Psoriatic; Arthritis, Rheumatoid; Psoriasis
Date of authorisation: 13/01/2016, , Revision: 19, Authorised, Last updated: 13/02/2023
List item

Human medicine European public assessment report (EPAR): Filgrastim Hexal

filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 06/02/2009, , Revision: 21, Authorised, Last updated: 10/02/2023
List item

Human medicine European public assessment report (EPAR): Zarzio

filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 06/02/2009, , Revision: 22, Authorised, Last updated: 10/02/2023
List item

Human medicine European public assessment report (EPAR): Zercepac

trastuzumab, Breast Neoplasms; Stomach Neoplasms
Date of authorisation: 27/07/2020, , , Revision: 8, Authorised, Last updated: 09/02/2023
List item

Human medicine European public assessment report (EPAR): Sylvant

siltuximab, Giant Lymph Node Hyperplasia
Date of authorisation: 22/05/2014, , , Revision: 12, Authorised, Last updated: 09/02/2023
List item

Human medicine European public assessment report (EPAR): Epclusa

Sofosbuvir, velpatasvir, Hepatitis C, Chronic
Date of authorisation: 06/07/2016, , Revision: 19, Authorised, Last updated: 09/02/2023
List item

Human medicine European public assessment report (EPAR): Harvoni

ledipasvir, Sofosbuvir, Hepatitis C, Chronic
Date of authorisation: 17/11/2014, , Revision: 27, Authorised, Last updated: 09/02/2023
List item

Human medicine European public assessment report (EPAR): Sovaldi

Sofosbuvir, Hepatitis C, Chronic
Date of authorisation: 16/01/2014, , Revision: 27, Authorised, Last updated: 09/02/2023
List item

Human medicine European public assessment report (EPAR): Defitelio

defibrotide, Hepatic Veno-Occlusive Disease
Date of authorisation: 18/10/2013, , , , Revision: 14, Authorised, Last updated: 09/02/2023
List item

Human medicine European public assessment report (EPAR): Spevigo

Spesolimab, Psoriasis
Date of authorisation: 09/12/2022, , , Authorised, Last updated: 08/02/2023
List item

Human medicine European public assessment report (EPAR): Flixabi

infliximab, Arthritis, Psoriatic; Spondylitis, Ankylosing; Colitis, Ulcerative; Arthritis, Rheumatoid; Crohn Disease; Psoriasis
Date of authorisation: 26/05/2016, , Revision: 23, Authorised, Last updated: 06/02/2023
List item

Human medicine European public assessment report (EPAR): Evrysdi

Risdiplam, Muscular Atrophy, Spinal
Date of authorisation: 26/03/2021, , , Revision: 3, Authorised, Last updated: 06/02/2023
List item

Human medicine European public assessment report (EPAR): Pandemic Influenza Vaccine H5N1 Baxter AG

influenza vaccine (whole virion, inactivated) containing antigen of: A/Vietnam/1203/2004 (H5N1), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 16/10/2009, , Revision: 8, Authorised, Last updated: 06/02/2023
List item

Human medicine European public assessment report (EPAR): Blitzima

rituximab, Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 13/07/2017, , Revision: 18, Authorised, Last updated: 02/02/2023
List item

Human medicine European public assessment report (EPAR): Ninlaro

ixazomib citrate, Multiple Myeloma
Date of authorisation: 21/11/2016, , , , Revision: 15, Authorised, Last updated: 01/02/2023
List item

Human medicine European public assessment report (EPAR): Truxima

rituximab, Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Wegener Granulomatosis; Leukemia, Lymphocytic, Chronic, B-Cell; Microscopic Polyangiitis
Date of authorisation: 17/02/2017, , Revision: 19, Authorised, Last updated: 31/01/2023